Literature DB >> 15499184

The organic anion transporter (OATP) family.

Tsuyoshi Mikkaichi1, Takehiro Suzuki, Masayuki Tanemoto, Sadayoshi Ito, Takaaki Abe.   

Abstract

In the last decade, many organic anion transporters have been isolated, characterized their distribution and substrates. The recently identified organic anion transporter family OATP (organic anion transporting polypeptide)/LST (liver-specific transporter) family, transport bile acids, hormones as well as eicosanoids, various compounds (BSP, HMG-CoA reductase inhibitor, angiotensin converting enzyme inhibitor, etc.). The isolation of the family revealed that not only hydrophilic compounds, drugs and hormones of lipophilic nature need a membrane transport system to penetrate cell membrane. In this family, the nomenclature becomes very complicated and the physiological role of this family is still unclear except about few organs such as the brain, liver and kidney. Even in such organs, the co-existence of the OATP/LST family and similar substrate specificity hamper the progress and clear characterization identifying the real role of the transporter family. Here, recent progress and an insight of this field are reviewed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499184     DOI: 10.2133/dmpk.19.171

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  33 in total

1.  Evidence for protein-mediated fatty acid efflux by adipocytes.

Authors:  A H Henkin; A M Ortegon; S Cho; W-J Shen; A Falcon; F B Kraemer; S-J Lee; A Stahl
Journal:  Acta Physiol (Oxf)       Date:  2011-10-25       Impact factor: 6.311

Review 2.  Pharmacogenetics in drug regulation: promise, potential and pitfalls.

Authors:  Rashmi R Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 3.  Pharmacogenomics of human OATP transporters.

Authors:  Jörg König; Annick Seithel; Ulrike Gradhand; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-09       Impact factor: 3.000

4.  Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters.

Authors:  Mitsunori Okabe; Gergely Szakács; Mark A Reimers; Toshihiro Suzuki; Matthew D Hall; Takaaki Abe; John N Weinstein; Michael M Gottesman
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

5.  Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.

Authors:  K Sakamoto; H Mikami; J Kimura
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 6.  Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.

Authors:  E G Quetglas; A Armuzzi; S Wigge; G Fiorino; L Barnscheid; M Froelich; Silvio Danese
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

7.  Tissue distribution and thyroid hormone effects on mRNA abundance for membrane transporters Mct8, Mct10, and organic anion-transporting polypeptides (Oatps) in a teleost fish.

Authors:  Amanda M Muzzio; Pamela D Noyes; Heather M Stapleton; Sean C Lema
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2013-10-08       Impact factor: 2.320

8.  Comparative bioinformatics, temporal and spatial expression analyses of Ixodes scapularis organic anion transporting polypeptides.

Authors:  Zeljko Radulović; Lindsay M Porter; Tae K Kim; Albert Mulenga
Journal:  Ticks Tick Borne Dis       Date:  2014-02-25       Impact factor: 3.744

9.  Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites.

Authors:  Brandon Swift; Noelia Nebot; Jin Kyung Lee; Tianxiang Han; William R Proctor; Dhiren R Thakker; Dieter Lang; Martin Radtke; Mark J Gnoth; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-03-12       Impact factor: 3.922

Review 10.  Impact of OATP transporters on pharmacokinetics.

Authors:  A Kalliokoski; M Niemi
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.